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Although foods are considered enhancing factors for dental caries and periodontitis, laboratory researches indicate that several
foods and beverages contain components endowed with antimicrobial and antiplaque activities. A low molecular mass (LMM)
fraction of an aqueous mushroom extract has been found to exert these activities in in vitro experiments against potential oral
pathogens. We therefore conducted a clinical trial in which we tested an LMM fraction of shiitake mushroom extract formulated
in a mouthrinse in 30 young volunteers, comparing the results with those obtained in two identical cohorts, one of which received
water (placebo) and the other Listerine. Plaque index, gingival index and bacterial counts in plaque samples were determined in
all volunteers over the 11 days of the clinical trial. Statistically signiﬁcant diﬀerences (P<0.05) were obtained for the plaque index
on day 12 in subjects treated with mushroom versus placebo, while for the gingival index signiﬁcant diﬀerences were found for
both mushroom versus placebo and mushroom versus Listerine. Decreases in total bacterial counts and in counts of speciﬁc oral
pathogenswereobservedforbothmushroomextractandListerineincomparisonwithplacebo.Thedatasuggestthatamushroom
extract may prove beneﬁcial in controlling dental caries and/or gingivitis/periodontitis.
1.Introduction
Dental plaque is a complex bacterial bioﬁlm associated
with tooth and gum surfaces [1, 2]. The so-called “plaque-
dependent” oral pathologies include dental caries and
periodontitis, with the former being the result of acid
destruction of the tooth enamel and dentin caused mainly by
Streptococcus mutans in the presence of sucrose [3], while the
latterresultsfromhostaggressiontothestructuresupporting
the teeth by a bacterial consortium, consisting mainly of
strict anaerobes [4]. Although foods, often in association
with poor oral hygiene, are considered enhancing factors
for these pathologies, a substantial amount of laboratory
research indicates that several foods and beverages of vegetal
origin contain components endowed with antimicrobial,
antiadhesive, and antiplaque activities (for a recent review2 Journal of Biomedicine and Biotechnology
see Signoretto et al. [5]). Thus, the consumption of such
healthy foods and beverages could be encouraged or foods
may be enriched with the active component(s). Several
epidemiologicalstudieshavebeenconductedindistinctpop-
ulations (Tibetans, Israeli Arabs, Senegalese, and Japanese,
English and US schoolchildren), comparing tea drinkers
versus nontea drinkers; the results showed a lower incidence
of caries in tea-drinkers [6, 7]. In addition, a signiﬁcant
reduction in both saliva and dental plaque counts of mutans
streptococci and lactobacilli has been observed, together
with a reduced plaque score in adult tea, coﬀee, and wine
drinkers versus water drinkers [8]. Very recently it has been
shown that the regular consumption of foods enriched with
these active molecules (wine and coﬀee) is associated with
a modiﬁcation of the oral microbial community in the
direction of less periodontopathogenic microbiota [9]. In
order to support the use of these substances as mouthrinses
or toothpastes in daily oral hygiene, a few clinical studies
havebeenconductedwithinteresting,thoughnotconclusive,
results. Tea and tea extracts [10, 11] and a high molecular
mass cranberry constituent [12] in mouthrinse formulations
have been tested in volunteers. A low molecular mass
(LMM) fraction of an aqueous mushroom extract (Lentinus
edodes, commonly called shiitake and very popular in Japan)
has been found to exert antimicrobial, antiadhesive, and
antiplaque activities in in vitro experiments against several
potential oral pathogens [13, 14]. We therefore conducted a
clinicaltrialin whichwetested anLMMfractionofashiitake
extract formulated in a mouthrinse in 30 young volunteers,
comparing the results with those obtained in two identical
cohorts, one of which received coloured and aromatised
water (placebo) and the other Listerine, a mouthwash used
worldwide.
2.MaterialsandMethods
2.1. Composition of Mouthrinses. Three diﬀerent mouth-
rinses were tested in this study. LMM fractions of the
mushroom extract mouthrinse as well as a mouthrinse
acting as a negative control (placebo) and composed of
aromatised water alone were prepared by MicroPharm Ltd,
Newcastle Emyln, UK. The aromatised water contained 12%
ethanol, 6% glycerine, 0.2% PEG 40 Hydrogenated Castor
Oil (Cremophor RH40), 0.2% ﬂavour, and 0.05% saccharin.
The LMM fraction of the mushroom extract mouthrinse
was obtained as described elsewhere [15]a n da d d e dt o
the aromatised water at a ﬁnal concentration of 2x in
comparison with the original food concentration. Twenty
mL of both mouthrinses were dispensed in 25mL tubes
and maintained at 4◦C in the dark for no more than 5
months. “Freshburst” Listerine (Johnson and Johnson, New
Brunswick, NJ, USA) was the one we tested as a positive
control. Listerine contained the following active ingredients:
0.092% eucalyptol, 0.042% mentol, 0.06% methyl salicylate
and 0.064% thymol in water, alcohol (21.6%), sorbitol
solution, ﬂavoring, poloxamer 407, benzoic acid, sodium
saccharin, sodium benzoate, D&C yellow no. 10, and FD&C
green no. 3. Listerine was removed from the original bottle
and 20mL aliquots were poured into tubes identical to those
of the other mouthrinses.
2.2. Volunteers Enrolled. A total of 90 healthy volunteers (49
males and 41 females, average age 22, range 19–27 years)
fromthestudentpopulationoftheUniversityofVeronawere
included in a three-leg, double-blind, clinical trial. Exclusion
criteria included antibiotic treatment at any time in the
3 months prior to the study, oral soft tissue pathologies,
missing teeth, visible untreated carious lesions, smoking,
and pregnancy. Subjects were randomly assigned to the
experimentalgroupinwhichmushroomwastested(n = 30),
to the negative/placebo (water) control group (n = 30) and
to the positive (Listerine) control (n = 30). All volunteers
were asked to sign an informed consent form.
2.3. Study Design. This clinical trial was authorised by
the Ethical Committee of the Verona University Hospital,
reference 1653 dated March 11, 2009. A three-leg, double-
blindstudywascarriedoutusingthethreemouthrinsestwice
daily for 12 days. The complete experimental period was 18
days (Figure 1). All participants were examined by a dentist
and subjected to professional oral hygiene treatment at time
0.Ondays1to6,allsubjectswereinvitedtomaintainregular
oral hygiene (brushing and ﬂossing) at home. On day 6 a
sample of dental plaque was collected along with clinical
measurements, as described below, and each participant
received the assigned mouthwash. From day 7 to day 17, they
were instructed to refrain from any type of oral hygiene and
to perform only two rinses with 10mL of mouthwash for
30sec at a 1min interval twice daily (morning and evening).
They were asked to refrain from eating and drinking 1 hour
after rinsing. On days 8, 10, 12, and 17, a subgingival plaque
sample was collected from each participant. Finally, on day
18 all the volunteers were subjected to professional oral
hygiene to restore oral health.
2.4.PlaqueIndex(PI)andGingivalIndex(GI)Determination.
The following measurements were performed on days 6, 8,
10, 12, and 17 of the study: (i) plaque index (PI) or plaque
accumulation was evaluated on the buccal surfaces following
the application of disclosing solution (Butler GUM, Butler,
Chicago, IL, USA), according to the Turesky modiﬁcation of
the Quigley-Hein plaque index [16]; (ii) gingival index or
gingival inﬂammation was assessed on the buccaland lingual
marginal gingivae and the interdental papillae, according to
the Loe-Silness gingivitis index [17].
2.5. Sample Collection for Microbiological Analysis. Dental
plaque samples were collected using a curette from two
upper molar surfaces on the left and right sides. Plaque was
dispersed in 750µL sterile Tris-EDTA buﬀer (10mM Tris-
HCL, 1mM EDTA, pH 8.0), vortexed for 1min to uniformly
dispersetheplaque,subdividedintothreealiquotsandstored
at −80◦C until further use.Journal of Biomedicine and Biotechnology 3
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Figure 1: Outline of the study. PI, plaque index; GI, gingival index.
2.6. Quantitative PCR (qPCR). DNA was extracted from
plaque bioﬁlms using a phenol:chloroform:iso-amyl alco-
hol (25:24:1) bead-beating extraction method [18], which
involves physical cell lysis, protein removal, and ﬁnally DNA
precipitation using polyethylene glycol. Three triplex qPCR
assays were then carried out using 2µL of extracted DNA
to quantify eight oral taxa as well as the total number
of organisms. The taxa investigated were Fusobacterium
nucleatum, Lactobacillus casei, Veillonella dispar, Neisseria
subﬂava,Actinomycesnaeslundii,Prevotellaintermedia,Strep-
tococcus sanguinis,a n dStreptococcus mutans. The assays were
performed using the Rotor-Gene 6500 (QIAGEN) instru-
ment and Sensimix Probe (Bioline) qPCR mix according to
the manufacturers’ instructions using previously published
oligonucleotide sequences [19].
2.7. Statistical Evaluation. Data collected were analysed by
usingtheStatisticalPackageforSocialSciences(SPSSversion
16.0).Foreachmouthwash,themeanandstandarddeviation
of the values was calculated. Data were analysed using one-
way analysis of variance (ANOVA) followed by Turesky test
for pairwise comparison. P values<0.05 were considered
statistically signiﬁcant.
3. Results
3.1. Clinical Evaluation of the Eﬀects of the Three Mouthrinses.
All 90 volunteers included in the three groups, one of
which received the mushroom mouthrinse, the second
colouredaromatisedwater(placebo),andthethirdListerine,
completed the study. At the beginning and on another four
Table 1: Cumulative plaque index scores (± standard deviation)
at the various test sessions during the treatment of volunteers with
three diﬀerent mouthwashes. Statistically signiﬁcant diﬀerences
(P<0.05) are marked by∗.
Test session Mushroom Water Listerine
Day 6 0.24 ±1.61 0.17 ±0.12 0.19 ± 0.18
Day 8 0.49 ±0.26 0.62 ±0.36 0.63 ± 0.34
Day 10 0.84 ±0.38 0.93 ±0.42 1.01 ± 0.39
Day 12 0.83 ±0.30∗ 1.04 ±0.41∗ 0.91 ± 0.38
Day 17 0.95 ±0.36 1.05 ±0.38 0.93 ± 0.34
Table 2: Cumulative gingival index scores (± standard deviation)
at the various test sessions during the treatment of volunteers with
three diﬀerent mouthwashes. Statistically signiﬁcant diﬀerences
(P<0.05) are marked by ∗ or ‡.
Test session Mushroom Water Listerine
Day 6 0.20 ±0.20 0.15 ±0.15 0.22 ±0.28
Day 8 0.26 ±0.18 0.31 ±0.25 0.27 ±0.20
Day 10 0.40 ±0.26 0.42 ±0.24 0.46 ±0.22
Day 12 0.53 ±0.30∗‡ 0.70 ±0.34∗ 0.69 ±0.32‡
Day 17 0.56 ±0.31 0.65 ±0.33 0.59 ±0.31
days of the period of mouthrinse use (Figure 1), clinical
parameters such as PI and GI were determined for all
volunteers. Table 1 shows the results of the PI calculation of
mean values ± SD. Mean values increased over time in the
three mouthrinse categories, but, as expected, the placebo
group showed the greatest increase. Signiﬁcant diﬀerences
(P<0.05) were observed on day 12 regarding mushroom
treatment versus placebo. A similar pattern was observed
when GI was evaluated (Table 2). GI values increased with
time, but, again, higher values were observed in the placebo
group in comparison with both the mushroom and Listerine
mouthrinses. Statistically signiﬁcant diﬀerences (P<0.05)
were obtained on day 12 for both mushroom versus placebo
and mushroom versus Listerine treatment.
3.2. Microbiological Measurement of the Eﬀects of the Three
Mouthrinses. At the time-points above indicated and also at
the time of collection of the clinical data, plaque samples
were obtained in order to determine the load of total bacteria
and of selected oral microorganisms by quantitative PCR
(pPCR). We quantiﬁed four microorganisms associated with
gingivitis(A.naeslundii,F. nucleatum,P.intermedia,L.casei),
one strongly implicated in dental caries (S. mutans), and
three microorganisms associated with oral health (S. sangui-
nis, N. subﬂava, V. dispar). The eight oral microorganisms
amounted to about 23 ± 6% of the total microbiota of
the dental plaque. Figure 2 shows the evolution of the four
microorganisms associated with gingivitis in comparison
with the total count during treatment with the three distinct
mouthrinses. In the placebo group, the mean total cell count
values increased over time (from 1.48 (±1.63) × 107 on day
6t o2 .27 (±0.99) × 108 on day 17). Standard deviation is
presented in brackets. Individual counts were F. nucleatum4 Journal of Biomedicine and Biotechnology
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Figure 2: Numbers of each of the investigated taxa associated with gingivitis and total counts in dental plaque samples of the three cohorts
enrolled in the study. Standard error bars represent the standard deviation (n = 30).
(from1.28 (±1.85)×106 to1.24 (±0.76)×107),P.intermedia
(from 4.89 (±10.3) × 104 to 4.53 (±3.25) × 105), and A.
naeslundii (from 5.48 (±8.35) × 105 to 2.99 (±3.72) × 106
on days 6 and 17, resp.) increased in accordance with the
total count, while L. casei, after an initial increase on day
10, tended to decrease (from 2.20 (±2.86) × 102 on day 6
to 6.43 (±2.86) × 103 on day 10 to 9.34 (±4.09) × 102 on
day 16). The oral rinses with mushroom or Listerine in
general did not block the increase either in total counts or in
those of the four gingivitis-associated microorganisms, but
these increases never exceeded half the ﬁnal value reported
for placebo. In detail, F. nucleatum during treatment with
mushroom increased from 2.23 (±2.95) × 106 on day 6 to
7.56 (±4.28) × 106 on day 17, and from 1.93 (±3.05) × 106
to 5.74 (±3.57) × 106 during treatment with Listerine; P.
intermediafrom3.71 (±7.72)×104 to2.60 (±6.66)×105 with
mushroomandfrom4.26 (±10.7)×104 to2.46 (±2.69)×105
with Listerine treatment; A. naeslundii from 1.41 (±2.27) ×
106 to 3.30 (±5.48) × 106 and from 1.15 (±2.03) × 106
to 9.70 (±10.4) × 105;a n dL. casei from 2.23 (±2.91) ×
102 to 9.28 (±2.76) × 102 and from 1.57 (±1.98) × 102
to 5.13 (±1.75) × 102 after treatment with mushroom and
Listerine, respectively. Figure 3 shows the eﬀects of the three
mouthrinses tested on the cariogenic S. mutans. In the
placebo group, the S. mutans cell count increased over time
(from 4.17 (±9.94) × 104 to 4.57 (±2.67) × 105)o nd a y
17. Although both mushroom and Listerine induced cell
number increases, the ﬁnal S. mutans values were lower
than those of the placebo group (i.e., 2.15 (±5.58) × 105
and 3.68 (1.15) × 105 for mushroom and Listerine, resp.).
Finally, Figure 4 shows the eﬀects of the three mouthrinses
on three microorganisms associated with oral health. S.
sanguinis, N. subﬂava, V. dispar counts increased (up to 2
log) over time from day 6 to day 17 in both the placebo and
mushroom groups. The values obtained were S. sanguinis
from1.60 (±2.26)×105 to3.92 (±1.03)×106 forplaceboand
from4.32 (±5.62)×105 to 2.53 (±0.62)×106 formushroom
group;N. subﬂava from 7.04 (±8.52)×105 to 4.48 (±0.45)×
107 and from 7.14 (±8.48) × 105 to 9.49 (±2.60) × 106
for placebo and mushroom, respectively; V. dispar from
1.31 (±2.36)×106 to 2.10 (±0.88)×107 and 2.48 (±3.28)×
106 to 1.37 (±0.31) × 107 for placebo and mushroom,Journal of Biomedicine and Biotechnology 5
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Figure 3: Numbers of S. mutans and total counts in dental plaque samples of the three cohorts enrolled in the study. Standard error bars
represent the standard deviation (n = 30).
respectively. Listerine, on the contrary, prevented any cell
number increase of N. subﬂava and V. dispar and, thus values
at day 17 were quite close to the initial (day 6) count (i.e.,
2.95 (±3.71) × 106 and 3.67 (±4.41) × 106,r e s p . ) .T h ec e l l
number increase of S. sanguinis was only partially aﬀected
by Listerine (from 1.87 (±3.40) × 105 to 1.51 (±3.20) ×
106). Although diﬀerences were seen, especially as far as the
placebo group versus mushroom or Listerine was concerned,
none of them proved statistically signiﬁcant.
4. Discussion
The aim of this clinical trial was to evaluate the possible
beneﬁcial eﬀects of an LMM mushroom extract formulated
as a mouthrinse in preventing dental plaque deposition in
volunteers. In addition, its activity was compared with the
activity of Listerine, a widely used mouthwash and with that
of a placebo composed of colored and aromatised water.
The rationale of this study was based on the proven in vitro
activity of this mushroom extract in terms of antimicrobial,
antiadhesive, antiplaque and plaque disaggregating activity
againstseveral oral microorganisms including those involved
either in dental caries or in gingivitis/periodontitis [13].
The results on the whole indicate that a mouthrinse
containing an LMM fraction of mushroom extract was capa-
ble of signiﬁcantly reducing dental plaque deposition as
comparedwithplacebo,butthisactivitywasnotsigniﬁcantly
higherthanthatdisplayed byListerine. Worthyofnote, how-
ever,isthefactthatinthepresentclinicaltrialListerinefailed
to prove signiﬁcantly more active than placebo, although
lower scores were determined. Equally interesting are the
results obtained when GI was evaluated. The mushroom
mouthwash showed a statistically signiﬁcant advantage over
both placebo and Listerine. This result may be attributed
to the ability displayed by the mushroom mouthwash to
reduce plaque deposition, but an anti-inﬂammatory activity
or a sort of gingival cell protection by the mushroom extract
may be suspected. Indeed, the LMM fraction of mushroom
extract, at concentrations that did not aﬀect the viability of
KB gingival cells, is capable of modulating the expression
of diﬀerent genes induced by both live and heat-killed P.
intermedia and A. naeslundii, thus supporting the hypothesis
that this foodstuﬀ extract can modulate the responses of
gingival cells to periodontopathogens [20]. The eﬀects of the
mushroom mouthrinse on both PI and GI are reminiscent
of those observed in oolong tea [11] and pomegranate [21]
extract which signiﬁcantly inhibit dental plaque deposition
in volunteers but diﬀer from those of nondialysable material
of cranberry juice [12]f o rw h i c hn oe ﬀect was detected
on either gingival or plaque indices after a 42-day study.6 Journal of Biomedicine and Biotechnology
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Figure 4: Numbers of each of the investigated taxa associated with oral health and total counts in dental plaque samples of the three cohorts
enrolled in the study. Standard error bars represent the standard deviation (n = 30).
Chlorhexidine, which is capable of aﬀecting both the clinical
parameters PI and GI, is endowed, however, with a potent
antibacterial activity [22, 23].
Although the mushroom mouthrinse is capable of signif-
icantly aﬀecting clinical parameters, no signiﬁcant reduction
of total cell count, or of the counts of speciﬁc microbial
components of dental plaque, was demonstrated. Some
ﬁndings, however, deserve attention: as far as the eﬀect
on total plaque bacteria count is concerned, mushroom
extract and Listerine may be equivalent in that they are
capable of a certain degree of inhibition in comparison
with the results of the placebo group, even if this activity
failed to prove statistically signiﬁcant. The partial activity
against total plaque bacteria was studied in greater detail
by analysing the eﬀects on selected bacteria responsible
for diﬀerent oral conditions, such as the evolution towards
gingivitis as indicated by the strict anaerobes F. nucleatum,
P. intermedia, A. naeslundii and L. casei, caries following
S. mutans, and the relationship between N. subﬂava, V.
dispar, and S. sanguinis and oral health [19]. Against bacteria
involved in gingivitis, mushroom extract and Listerine
behaved similarly, inhibiting the increase in cell number in
dental plaque of three out of four microorganisms tested
(not including L. casei) to such an extent that the ﬁnal
number (day 17) is less than the half that of the placebo
group. Although inhibition of the cell number increase is
calculated as being about half the control value, it is worth
noting that this inhibition is mainly attributable to strict
oral anaerobes, whose role in the evolution of gingivitis
towards periodontitis is fully ascertained [3, 4]. Against
cariogenic S. mutans both mushroom and Listerine exerted
a certain action, with cell counts on day 17 being roughly
50% lower than the control values. Also of interest are the
results of the eﬀects of the three mouthrinses on bacteria
associated with oral health: a good candidate for formulating
a mouthrinse should aﬀect only potential oral pathogens,
leaving that portion of oral microbiota associated with oral
health unaltered. Mushroom extract seems to comply with
this requirement in that it showed no eﬀect mainly on
gram-negatives (N. subﬂava and V. dispar) and only partial
inhibition of S. sanguinis. From this point of view, the action
of mushroom extract would appear to be superior to that
of Listerine, with the latter being an inhibitor also of the
microbiota associated with oral health. These results are
in agreement with those obtained by Ciric et al. [24]w h o
have tested the activity of the same mushroom fraction in
an artiﬁcial mouth model (constant depth ﬁlm fermentor)
and shown that mushroom fraction lowered the numbers ofJournal of Biomedicine and Biotechnology 7
some pathogenic taxa without aﬀecting the taxa associated
with oral health.
Although the microbiological results of the eﬀect of
the mushroom mouthrinse would appear to be in contrast
with in vitro results which show antimicrobial, antiadhesive,
antiplaque, and plaque disaggregating activities [13, 14], this
incongruity may be explained by the fact that these activities
were not relevant during the clinical trial or, alternatively,
the experimental design was incapable of detecting them if
present. Thus, on the basis of the promising eﬀects on clin-
ical parameters obtained with the mushroom mouthrinse,
further studies conducted both in vitro and in humans are
advisable.
The possibility of using mouthrinses containing active
componentsofnaturaloriginfordailyoralhygienemaycon-
stitute a novel approach in order to alter bioﬁlm formation
on tooth and gum surfaces. Their potential for controlling
dental caries and/or gingivitis/periodontitis warrants further
investigation.
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